Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Avram

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
The impact of CAPD treatment on lipid metabolism and cardiovascular riskD Tan, P A Fein, A Antignani, et al.
JAMA|June 30, 1978
Persistent nocardemia following renal transplantation. Association with pulmonary nocardiosisM M Avram, S R Nair, H I Lipner, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1976
Metabolic changes in diabetic uremic patients on hemodialysisM M Avram, H I Lipner, R Sadiqali, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1996
Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremiaM M Avram, R Sreedhara, D K Avram, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?M M Avram, R Sreedhara, N Patel, et al.
ASAIO Transactions|July 1, 1990
Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patientsD Burrell, A Antignani, P A Fein, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Peritonitis and the patient with human immunodeficiency virus (HIV)T Schloth, I Genabe, W Pilgrim, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1978
Continuous low-dose insulin infusion in diabetics receiving peritoneal dialysisA L Zimmerman, J I Cohn, R Ranieri, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 13, 2001
Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parametersM M Avram, R Sreedhara, P Fein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1992
The uremic dyslipidemia: a cross-sectional and longitudinal studyM M Avram, P Goldwasser, D E Burrell, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
The impact of CAPD treatment on lipid metabolism and cardiovascular riskD Tan, P A Fein, A Antignani, et al.
JAMA|June 30, 1978
Persistent nocardemia following renal transplantation. Association with pulmonary nocardiosisM M Avram, S R Nair, H I Lipner, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1976
Metabolic changes in diabetic uremic patients on hemodialysisM M Avram, H I Lipner, R Sadiqali, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1996
Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremiaM M Avram, R Sreedhara, D K Avram, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?M M Avram, R Sreedhara, N Patel, et al.
ASAIO Transactions|July 1, 1990
Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patientsD Burrell, A Antignani, P A Fein, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Peritonitis and the patient with human immunodeficiency virus (HIV)T Schloth, I Genabe, W Pilgrim, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1978
Continuous low-dose insulin infusion in diabetics receiving peritoneal dialysisA L Zimmerman, J I Cohn, R Ranieri, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 13, 2001
Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parametersM M Avram, R Sreedhara, P Fein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1992
The uremic dyslipidemia: a cross-sectional and longitudinal studyM M Avram, P Goldwasser, D E Burrell, et al.
Pageof 8